AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04443036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-Bound Paclitaxel
Description: * 125mg/m2 IV d1、8，Q3W~* until disease progression, lost follow-up visit, death , unacceptable toxicity
Study NCT04443036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: * 240 mg，IV d1，Q3W~* until disease progression, lost follow-up visit, death , unacceptable toxicity, Maximum treatment duration is 24 months
Study NCT01861613 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium)
Study NCT04509557 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [177Lu]Ludotadipep
Description: Dose is sequentially elevated starting from a low dose to a high dose (50±5 mCi, 75±8 mCi, 100±10 mCi, 125±13 mCi, 150±15 mCi). If DLT is observed in 2 or less of 6 subjects at each level, advance to the next step. If DLT is observed in 3 or more participants, no further subject will participate in the study at the relevant dose. Appropriateness of the dose elevation is evaluated 8-9 weeks after drug administration.
Study NCT05455255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: FL was applied by Jonathan Bergmann and Aaron Sams in 2007 for high school students who had to be absent from chemistry class. Bergmann and Sams published all the learning activities they used during the lesson as videos. Bergmann and Sams (2012) stated that in this model, which they developed over time, it is not compulsory for the trainer to explain the entire course content in the videos, and the important thing is to allocate time to active learning methods during the course. In the FL model, the summary of the course content is presented to the individuals outside the classroom with tools such as video and power point presentations. In the lesson, activities are carried out for the active participation of the student. The student performs the course content outside of the classroom, and the homework and learning the course in the classroom.
Study NCT03815760 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction
Description: Subjects will perform sidelying external rotation exercise
Study NCT03815760 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Blood Flow Restriction
Description: Subjects will perform sidelying external rotation exercise
Study NCT00861094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Study NCT00861094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FU
Study NCT00861094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Study NCT00861094 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Study NCT00861094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folinic Acid
Study NCT02406339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NMES
Description: Neuromuscular Electrical Stimulation
Study NCT02406339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vascular Occlusion
Description: Restriction of sanguine flow to the lower limbs
Study NCT03465124 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Femtosecond Laser
Description: Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order. Contralateral eye will receive conventional cataract surgery
Study NCT00881140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mifepristone vaginal tablets
Description: Daily use of 10 mg administrated per vagina for 3 months
Study NCT02823236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical Pirfenidone
Description: Pirfenidone 8% gel will be applied three times per day during 6 months in the surface of the keloid scar.
Study NCT02823236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triamcinolone + Pirfenidone
Description: Triamcinolone will be injected in the keloid scar 4 mg/cm2 every 4 weeks for 6 months. And pirfenidone 8% gel will be applied three times per day during 6 months in the surface of the keloid scar.
Study NCT02823236 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intralesional Triamcinolone
Description: Triamcinolone will be injected in the keloid scar 4 mg/cm2 every 4 weeks for 6 months.
Study NCT02869685 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: radiotherapy
Description: radiotherapy
Study NCT03821480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test drug
Description: Fluconazole capsule 50 mg Manufacturer: West Ryde
Study NCT03821480 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference drug
Description: Fluconazole capsule 50 mg Manufacturer: Amboise
Study NCT03961893 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: G-EYE first and standard colonoscope
Description: Patients undergo two successive colonoscopies, first balloon-assisted colonoscopy (G-EYE device) and then standard colonoscopy
Study NCT03961893 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: standard colonoscope first and G-EYE
Description: Patients undergo two successive colonoscopies, first standard colonoscopy and then balloon-assisted colonoscopy (G-EYE device)
Study NCT03694067 — intervention group
Intervention type: OTHER
Intervention: Punch skin biopsy
Description: One 1 mm punch biopsy will be taken from the patients from balding scalp. Another 1 mm punch biopsy will be taken from an area of occipital non-balding scalp of the same individual. Local anesthesia will be injected around the biopsy site beforehand.
Study NCT01942408 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Repeat PVI
Description: Repeat EP study 8-10 weeks post-initial PVI with re-isolation of PV reconnection
Study NCT00711412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Induction Therapy - Capecitabine
Description: Two 21-day cycles will be given as induction. Capecitabine will be given at 1000 mg/m2 twice daily approximately 12 hours apart for 14 days, followed by seven days off.
Study NCT00711412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Induction Therapy - Oxaliplatin
Description: Two 21-day cycles will be given as induction. Oxaliplatin will be given at 70 mg/m2 intravenously in 5% dextrose over two hours on days 1 and 8 of each cycle.
Study NCT00711412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination Therapy - Capecitabine
Description: Two 21-day cycles will be given for combination therapy. Capecitabine will be given at 825 mg/m2 twice daily approximately 12 hours apart for five days (Monday through Friday) followed by two days off for 51/2 weeks.
Study NCT00711412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination Therapy - Oxaliplatin
Description: Two 21-day cycles will be given. Oxaliplatin will be given at 50 mg/m2 intravenously in 5% dextrose over two hours on days 1, 8 and 15 of each cycle.
Study NCT03465124 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual Cataract Surgery
Description: conventional cataract surgery as control
Study NCT00174954 — intervention group
Intervention type: PROCEDURE
Intervention: MRI
Description: Subjects underwent MRI to evaluate tophi.
Study NCT00818688 — intervention group
Intervention type: PROCEDURE
Intervention: compression ultrasonography at 3 months
Description: A three-month follow-up prospective study was performed in the subgroup of patients with symptomatic ST but without deep-vein thrombosis on compression ultrasonography or documented symptomatic pulmonary embolism at inclusion, a group defined as patients with 'isolated ST'.
Study NCT00711412 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Combination Therapy - Radiation
Description: 1.8 Gy daily Monday through Friday to a total of 50.4 Gy for 6 weeks during combination therapy.
Study NCT00090363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD4054 15 mg
Description: 15 mg oral tablet once daily
Study NCT00090363 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00090363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD4054 10 mg
Description: 10mg oral tablet once daily
Study NCT03963986 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: STIMUL group
Description: The STIMUL Group participants in the Adaptive Physical Activity Focus (APA) program receive access to an online digital Platform, as well as a starter kit consisting of a connected pedometer measuring several physical activity indicators including the number of steps, number of so-called active minutes, sleep time, and distance travelled; a tape measure and a starter guide. They then conduct a remote assessment and motivational interview by videoconference or telephone, followed by 15-20 minute support interviews (month 1, month 3, month 6). Between these interviews, during months 1, 2, and 3, participants exchange weekly written messages with an educator on their platform. A planner of their physical activity objectives is provided.
Study NCT03735316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxocobalamin
Description: 5g, IV, Infused once over 15 minutes. The drug comes in a 250ml glass vial with 5g of lyophilized hydroxocobalamin to be reconstituted in 200ml of Normal Saline, Dextrose or Lactated Ringers.
Study NCT00711412 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Evaluation for response and surgery
Description: Four to eight weeks following the completion of therapy subjects will undergo evaluation for response and surgical resection.
Study NCT03735316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary Bypass
Description: Technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the patient's body.
Study NCT03735316 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Cardiopulmonary Bypass
Description: Technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the patient's body.
Study NCT03735316 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Placebo is a Normal Saline, 5g, IV, Infused once over 15 minutes. The placebo comes in a 250ml glass vial.
Study NCT00727870 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Shapes by PolyMem dressing
Description: Shapes by PolyMem dressing on one site compared to antibiotic ointment covered with band-aid type dressing on second site
Study NCT00727870 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Shapes by PolyMem Silver Dressing
Description: Shapes by PolyMem Silver dressing on one site compared to antibiotic ointment covered with band-aid type dressing on second site
Study NCT00727870 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Shapes by PolyMem on one site and Shapes by PolyMem Silver dressing on second site
Description: Shapes by PolyMem dressing on one site. Shapes by PolyMem Silver dressing on other site.
Study NCT00952211 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP
Description: CPAP at therapeutic pressure during nighttime
Study NCT03976557 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BIP CVC
Description: Central venous access with noble metal coated CVC
Study NCT03976557 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard CVC
Description: Central venous access with standard uncoated CVC
Study NCT02724280 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: WLE and then LCI
Description: The gastric mucosa was evaluated with WLE and then LCI by two different endoscopists.
Study NCT02724280 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: LCI and then WLE
Description: The gastric mucosa was evaluated with LCI and then WLE by two different endoscopists.
Study NCT00952211 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: CPAP at sub-therapeutic pressure
Description: CPAP delivered at sub-therapeutic pressure at nighttime
Study NCT00094861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palifermin
Study NCT00628342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Description: 20mg Oral tablet once daily
Study NCT00628342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Description: 40mg Oral tablet once daily
Study NCT00628342 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral once daily
Study NCT01770886 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: UE2343
Description: Oral capsule
Study NCT01770886 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral capsule
Study NCT00943410 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: external beam radiation therapy
Description: Radiation therapy will consist of 50Gy in 2Gy fractions to the breast/chest wall and regional lymphatics for 5 consecutive days up to 5 weeks for surgical candidates and 7 weeks for non-surgical candidates
Study NCT00943410 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Herceptin
Description: Patients who are already receiving weekly Herceptin® will continue weekly Herceptin®, 2mg/kg IV on day 1 of each week of radiotherapy. Patients who have not been receiving weekly Herceptin® as a component of systemic therapy will begin Herceptin® one week prior to beginning radiotherapy with a loading dose of 4mg/kg followed by weekly Herceptin® at 2mg/kg on day 1 of each week of radiotherapy
Study NCT01840436 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MUCIPLIQ
Description: MUCIPLIQ is applied by mouthwash, for 2 to 3 minutes before being spat out, twice a day.
Study NCT01840436 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is applied by mouthwash, for 2 to 3 minutes before being spat out, twice a day.
Study NCT00441727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Description: Esomeprazole 40 mg once daily
Study NCT00441727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Description: Esomeprazole 20 mg once daily
Study NCT00441727 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo once daily
Study NCT04827940 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Progressive relaxation exercise with music
Description: The progressive relaxation technique includes exercises for the muscles in the body to consciously contract and relax together with deep breathing exercises while sitting comfortably or lying down accompanied by music.~Relaxing relaxation music for sleep, prepared by the Turkish Psychologists Association, has been installed on the mobile phones of the patients.~The patients did the relaxation exercises for an average of 30 minutes before going to bed for a week and every day with music.Relaxing relaxation music for sleep, prepared by the Turkish Psychologists Association, has been installed on the mobile phones of the patients.~The patients were taught to do the relaxation exercises for an average of 30 minutes before going to bed for a week and every day with music.
Study NCT04827940 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercise with music
Description: The progressive relaxation technique includes exercises for the muscles in the body to consciously contract and relax together with deep breathing exercises while sitting comfortably or lying down accompanied by music.~Relaxing relaxation music for sleep, prepared by the Turkish Psychologists Association, has been installed on the mobile phones of the patients.~The patients did the relaxation exercises for an average of 30 minutes before going to bed for a week and every day with music.Relaxing relaxation music for sleep, prepared by the Turkish Psychologists Association, has been installed on the mobile phones of the patients.~The patients were taught to do the relaxation exercises for an average of 30 minutes before going to bed for a week and every day with music.
Study NCT03066310 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Next generation sequencing
Description: The obtained DNA from the urine, blood and tumor (optional) will be tested by next generation sequencing for each arm.
Study NCT01111721 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project POWER HIV Risk-reduction Intervention
Description: Nine session group-based behavioral intervention for incarcerated female adults.
Study NCT01111721 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NC DOC Standard of Care for STIs
Description: Standard North Carolina Department of Correction intake STI testing and counseling.
Study NCT04171167 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasone Propionate
Description: three visits: 0, after washout, after FP usage
Study NCT00074152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chemotherapy
Description: Given within 10 weeks after surgery.
Study NCT00074152 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy
Description: Given within 6 months after surgery
Study NCT03780985 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intrauterine device insertion
Description: Post-placental insertion of intrauterine device during Cesarean section
Study NCT03780985 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cesarean section
Description: to delivery of the fetus
Study NCT03780985 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suture
Description: to fix the intrauterine device
Study NCT03696849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: polished emax Press
Description: lithium disilicate glass ceramic crowns subjected to polishing only
Study NCT03696849 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: polished emax Press
Description: lithium disilicate glass ceramic crowns subjected to polishing only
Study NCT00054756 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRH (Thyrotropin Releasing Hormone)
Study NCT04601181 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ThisCART22 cells injection
Description: Assigned Interventions Biological/Vaccine: ThisCART22 cells 0.2-60 x 10\^6 CAR-T cells per kg body weight.~Intervention study
Study NCT06000215 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Perineal/introital ultrasound examination, two different examiners. The examiners are blinded to each other and to the previous prolapse surgery.
Description: Each examiner to answer:~1. Is there a mesh or not: Yes or No~2. If Yes:~   * Which type of mesh? Uphold, Pinnacle Posterior or Artisyn® Y-Shaped Mesh~  * What is the length of the mesh in a single midsagittal view image~3. Examination record time is to be registered.
Study NCT06000215 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Perineal/introital ultrasound examination, two different examiners. The examiners is now being informed of the previous prolapse surgery.
Description: Each examiner to answer:~1. Is there a mesh or not: Yes or No~2. If Yes:~   * Which type of mesh? Uphold, Pinnacle Posterior or Artisyn® Y-Shaped Mesh~  * What is the length of the mesh in a single midsagittal view image~3. Examination record time is to be registered.
Study NCT02147691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azelaic acid 15%
Description: Applied to the face each AM and PM
Study NCT00094861 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00094861 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Study NCT00094861 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Radiotherapy
Study NCT00094861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Study NCT00094861 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paclitaxel
Study NCT01534741 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: dialyzer comparison
Description: Each patient will be treated by post-dilution online hemodiafiltration once with each dialyzer type (FX CorDiax 60or FX 60 ) The order of dialyzers used will be randomly assigned to the patient at the time of randomisation by lot. Every subject will be treated one time with each dialyzer. In order to achieve controlled conditions, the mid- or end-week session data will be used, only.
Study NCT01534741 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dialyzer
Description: Comparison Dialyzer FX60 versus Cordiax60
Study NCT00094861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Study NCT03560232 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ceftriaxone
Description: See arm description
Study NCT03560232 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ampicillin/sulbactam
Description: See arm description
Study NCT03560232 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Piperacillin/tazobactam
Description: See arm description
Study NCT03003624 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colorado® microdissection needle
Description: The primary feature of the Colorado® microdissection needle is the ultra-sharp tungsten tip that delivers the wave-form from the electrosurgery generator to a very small spot. This allows the use of extremely low wattages, resulting in less tissue necrosis, precision cutting and cautery, and less post-operative pain.